Monsanto’s venture arm leads $24m Series C

The firm co-led the round in biologicals start-up NewLeaf Symbiotics alongside Otter Capital, bringing capital raised by the company to nearly $50m.

To view this content you must sign in:

Not yet registered? Join today to access Agri Investor's industry insights and updates.